10 likes | 79 Views
Explore the influence of recombinant human TSH on thyroid cancer management through whole-body scans and radioiodine retention, comparing it to traditional thyroid hormone withdrawal. This study by Schlumberger et al. (2007) sheds light on the evolving practices in patient care post-thyroid cancer diagnosis.
E N D
Figure 2 Examples of whole body scans and whole body radioiodine retention either after administration of rhTSH or after THW Schlumberger M et al. (2007) How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer Nat Clin Pract Endocrinol Metab3: 641–650 doi:10.1038/ncpendmet0594